Implementation of MISSION-Criminal Justice in a Treatment Court: Preliminary Outcomes Among Individuals With Co-occurring Disorders.


Journal

Psychiatric services (Washington, D.C.)
ISSN: 1557-9700
Titre abrégé: Psychiatr Serv
Pays: United States
ID NLM: 9502838

Informations de publication

Date de publication:
01 11 2019
Historique:
pubmed: 25 7 2019
medline: 1 8 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

Mental health courts provide an alternative to incarceration and address both mental health and criminal justice needs. Many individuals within these treatment courts also have co-occurring substance use disorders. This pilot study examined the preliminary effectiveness of Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ), an intervention that targets co-occurring disorders and criminal justice risk factors within a mental health court. Participants (N=97) were enrolled in mental health court and MISSION-CJ community wraparound services. Participants were primarily male with an average age of 34, had spent an average of more than 5 years incarcerated, and had an average of 13.94 years of illegal drug use; 91% had experienced depression. Preliminary 6-month outcomes showed significant reduction in nights incarcerated (p<0.002), illegal drug use (p<0.003), trauma symptoms (p<0.004), and behavioral health symptoms (p<0.006). Preliminary findings suggest promise for delivery of MISSION-CJ to participants in a mental health court.

Identifiants

pubmed: 31337322
doi: 10.1176/appi.ps.201800570
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1044-1048

Commentaires et corrections

Type : CommentIn

Auteurs

Debra A Pinals (DA)

Department of Psychiatry, Law, and Ethics, University of Michigan Medical School, Ann Arbor (Pinals); Department of Psychiatry, Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester (Gaba, Clary, Smelson); Massachusetts Department of Mental Health, Boston (Barber); Behavioral Health Network, Inc., Springfield, Massachusetts (Reiss).

Ayorkor Gaba (A)

Department of Psychiatry, Law, and Ethics, University of Michigan Medical School, Ann Arbor (Pinals); Department of Psychiatry, Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester (Gaba, Clary, Smelson); Massachusetts Department of Mental Health, Boston (Barber); Behavioral Health Network, Inc., Springfield, Massachusetts (Reiss).

Kelsey M Clary (KM)

Department of Psychiatry, Law, and Ethics, University of Michigan Medical School, Ann Arbor (Pinals); Department of Psychiatry, Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester (Gaba, Clary, Smelson); Massachusetts Department of Mental Health, Boston (Barber); Behavioral Health Network, Inc., Springfield, Massachusetts (Reiss).

John Barber (J)

Department of Psychiatry, Law, and Ethics, University of Michigan Medical School, Ann Arbor (Pinals); Department of Psychiatry, Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester (Gaba, Clary, Smelson); Massachusetts Department of Mental Health, Boston (Barber); Behavioral Health Network, Inc., Springfield, Massachusetts (Reiss).

Juliana Reiss (J)

Department of Psychiatry, Law, and Ethics, University of Michigan Medical School, Ann Arbor (Pinals); Department of Psychiatry, Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester (Gaba, Clary, Smelson); Massachusetts Department of Mental Health, Boston (Barber); Behavioral Health Network, Inc., Springfield, Massachusetts (Reiss).

David Smelson (D)

Department of Psychiatry, Law, and Ethics, University of Michigan Medical School, Ann Arbor (Pinals); Department of Psychiatry, Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester (Gaba, Clary, Smelson); Massachusetts Department of Mental Health, Boston (Barber); Behavioral Health Network, Inc., Springfield, Massachusetts (Reiss).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH